Reviewer #1, whoever you are, I hope we meet again...

200 patients enrolled into @MegaROXtrial in 1 week! Patient 39600 enrolled this morning by Westmead Hospital, Australia. @DogICUma @DianeMackle @AnneMather__

Palantir 🤝 NVIDIA "This is probably the single most important enterprise stack in the world, the Palantir Ontology."

We may have been quiet on X... but behind the scenes has been BUSY. There are now less than 600 patients to go! @MegaROXtrial

An extra paper just published highlighting Rinaldo Bellomo's contribution to nephrology https://t.co/uGMfre5s5p

📣 Call for Papers ! Systematic Reviews & Meta-Analysis Critical Care Science welcomes submissions of #SystematicReviews & MetaAnalyses 🗝️topics in #ICU #PedsICU 💎 Open Access:  No APCs. No submission fees 👉 Submit your manuscript at: https://t.co/WWQKE2qUu1 #Foamed

Model Y Standard & Model 3 Standard are here

A special issue from @CCRJournal honouring the legacy of Rinaldo Bellomo Grab a coffee, sit back, read and smile. Such an incredible person. An uplifting tribute. Kudos to the authors for sharing their experiences https://t.co/l6Fs46uGz2

We have a new publication in Crit Care Resus: A legacy in print: The publication impact of Professor Rinaldo Bellomo https://t.co/AwMYx96rvt

The September issue of Critical Care and Resuscitation is now online. An entire issue dedicated to the extraordinary legacy of Rinaldo Bellomo: https://t.co/J5pwPczmDL

The #MegaROXtrial has 1300 to go (which will take 39 days +/-2)

SHEIN’s on-demand model leverages real-time data to create what customers want, reducing overproduction and waste while improving efficiency in fashion.

🚩ImmunoSep Trial 🚩 👥 n=280 🧪 RCT of precision immunotherapy in sepsis 🔬 Stratified by immune endotype  🔥 Hyperinflammation → Anakinra  🛡️ Immunoparalysis → Interferon-γ 📊 First results coming at #CCRDownUnder 2025 Join us in Melbourne! https://t.co/72daQZImLO

#MegaROXtrial 1500 to go.

Latest trial announcement - CLIP II Cryopreserved platelets vs liquid platelets for the management of post operative bleeding in patients undergoing cardiac surgery. To be presented by @reade_m Join us in Melbourne - https://t.co/72daQZImLO

🚩100 Days to CCR Down Under 2025🚩 ➡️ Join us in Melbourne to hear the results of the latest major critical care trials ➡️ In person & virtual registrations available ➡️ Run in partnership with @intensiveblog & @MonashUni https://t.co/72daQZImLO

Securing our borders to keep fentanyl out of our country.

We have a new publication in BJA Education: Ventilator-associated pneumonia. https://t.co/KF87PKDDyq

https://t.co/5FCnznv9dA

Professor Rinaldo Bellomo was one of the most influential scientists and a true giant in critical care medicine. Here are four editorials in his memory — honoring not only the brilliant researcher, but also the remarkable man behind the science. @MRE_signavitae @yourICM

In memory of Professor Rinaldo Bellomo AO, a giant of intensive care medicine Our latest CCRJ article pays tribute to Rinaldo Bellomo's life and legacy. The September issue will be dedicated entirely to his contributions. Remembering Rinaldo is here: https://t.co/Dy03hBLiSy

This Breast Cancer Awareness Month, look into Atossa Therapeutics. We’re advancing an (Z)-endoxifen (investigational) program to address important unmet needs in breast health. Review our science, our team, & our balance sheet. Then decide for yourself. Nasdaq: ATOS

@YukiKotani5 135 #MEGARoxtrial patients randomized in @SRAnesthesiaICU by @GiacomoMonti @DogICUma

We have enrolled 35789 patients into the @MegaROXtrial so far so we will soon see; we should complete enrolment this year.

Heterogeneity of treatment effect seems likely and a benefit from conservative oxygen for patients with COVID-19, in particular, is probable.

I don't think we can exclude a small but potentially clinically important increase in average mortality with the use of conservative oxygen therapy.

ACC CEO @DanielleBFranz takes the @TEDTalks stage to share why ACC was founded to engage young conservatives on environmental issues: “I realized that we couldn’t leave climate change to one political party alone.”